Anti-HBs, Anti-HBc and Anti-HBc IgM are used as an aid in the diagnosis of Hepatitis B Virus (HBV) infection - Argentina Medical Device Registration
Access comprehensive regulatory information for Anti-HBs, Anti-HBc and Anti-HBc IgM are used as an aid in the diagnosis of Hepatitis B Virus (HBV) infection in the Argentina medical device market through Pure Global AI's free database. This Registration of products for IVD diagnostics - Group C and D medical device is registered with Argentina's ANMAT (National Administration of Drugs, Food and Medical Technology). The device was registered on July 19, 2024.
This page provides complete registration details including product code (1716-261), brand name (MAGLUMI), authorized representative information, registration type, and regulatory compliance data from the official Argentina ANMAT medical device database. Pure Global AI offers free access to Argentina's medical device registry, helping global MedTech companies navigate Argentina regulations efficiently.
1.- MAGLUMI Anti-HBs (CLIA) 2.- Anti-HBc MAGLUMAS (CLIA) 3.- Anti-HBc IgM MAGLUMAS (CLIA) 4.- MAGLUMI Anti-HBs (CLIA) Controls 5.- MAGLUMI Anti-HBc (CLIA) Controls 6.- MAGLUMI Anti-HBc IgM (CLIA) Controls
1.- MAGLUMI Anti-HBs (CLIA) 2.- MAGLUMI Anti-HBc (CLIA) 3.- MAGLUMI Anti-HBc IgM (CLIA) 4.- MAGLUMI Anti-HBs (CLIA) Controls 5.- MAGLUMI Anti-HBc (CLIA) Controls 6.- MAGLUMI Anti-HBc IgM (CLIA) Controls

